BioArctic AB/Skr BIOA B
08:00
10:05
12:15
14:20
16:25
1D1W1MYTD1Y5YMAX
About BioArctic AB
BioArctic AB is a Swedish biopharmaceutical company focusing on developing treatments for central nervous system disorders. The company is notably engaged in the research and development of therapies for neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. Founded in 2003, BioArctic collaborates with academic institutions and global pharmaceutical companies to advance its innovative approaches. The company is headquartered in Stockholm, Sweden, and leverages its strategic partnerships and scientific expertise to address unmet medical needs in its chosen field. BioArctic's competitive strengths include its proprietary technology platforms and strong intellectual property portfolio.
Ticker
Skr BIOA B
Sector
Primary listing
XSTO
Employees
122
Headquarters
Stockholm, Sweden
Website
BioArctic AB Metrics
BasicAdvanced
kr 50B
29.57
kr 11.25
-0.92
-
Price and volume
Market cap
kr 50B
Beta
-0.92
52-week high
kr 347.60
52-week low
kr 154.40
Average daily volume
205K
Financial strength
Current ratio
4.18
Quick ratio
3.136
Long term debt to equity
1.614
Total debt to equity
2.364
Interest coverage (TTM)
40.41%
Profitability
Gross margin (TTM)
97.08%
Net profit margin (TTM)
52.17%
Operating margin (TTM)
67.02%
Effective tax rate (TTM)
14.75%
Revenue per employee (TTM)
kr 15,710,000
Management effectiveness
Return on assets (TTM)
43.46%
Return on equity (TTM)
69.23%
Valuation
Price to earnings (TTM)
29.571
Price to revenue (TTM)
15.377
Price to book
15.01
Price to tangible book (TTM)
15.01
Price to free cash flow (TTM)
27.701
Free cash flow yield (TTM)
3.61%
Free cash flow per share (TTM)
12.014
Growth
Revenue change (TTM)
1,046.52%
Earnings per share change (TTM)
-526.64%
3-year revenue growth (CAGR)
102.21%
3-year earnings per share growth (CAGR)
229.74%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BioArctic AB stock?
BioArctic AB (BIOA B) has a market cap of Skr50B as of January 29, 2026.
What is the P/E ratio for BioArctic AB stock?
The price to earnings (P/E) ratio for BioArctic AB (BIOA B) stock is 29.57 as of January 29, 2026.
Does BioArctic AB stock pay dividends?
No, BioArctic AB (BIOA B) stock does not pay dividends to its shareholders as of January 29, 2026.
When is the next BioArctic AB dividend payment date?
BioArctic AB (BIOA B) stock does not pay dividends to its shareholders.
What is the beta indicator for BioArctic AB?
BioArctic AB (BIOA B) has a beta rating of -0.92. This means that it has an inverse relation to market volatility.